LEE GARY K. (Chief Scientific Officer) sold 0.7% of their position (130.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $2.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2026ACC: 0001907345-26-000003
Officer· Chief Scientific Officer
Since Jan 2022
-130.00
Net shares
Net seller
$2.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
130.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−130.00
Price / share
$18.92
Trade value
$2.46K
% of position
0.7%
5/11/2026
17.94K→17.81K
Total
Net shares
−130.00
Net value
-$2.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | S · Sale | −130.00 | $18.92 | $2.46K | 0.7% | 17.94K | 17.81K |
| Total | −130.00 | -$2.46K | ||||||
Derivative Transactions0
No derivative transactions reported